NEFL and myeloid sarcoma: Thus, to identify whether there is a correlation between DTI-MRI metrics and another promising NfL biomarker, Saraste et al. indicated an increase in serum NfL level accompanied by a variation in DTI-MRI metrics, where a decrease in FA was observed along with an increase in RD in NAWM in MS patients [187].